丙泊酚与阿片类药物致血流动力学不稳的非遗传与遗传预测因素:回顾性临床研究
该回顾性研究纳入150例中国甲状腺或乳腺手术患者,记录丙泊酚靶控浓度、阿片剂量、心率、平均动脉压及Narcotrend指数,并对候选单核苷酸多态性分型。结果显示基线心率与基线平均动脉压显著影响血流动力学不稳,GABRB1、OPRM1、CES2、NR1I2、BDNF及GABBR2多态性与心率或平均动脉压不稳相关,并建立了预测模型。
要点
- 基线心率与基线平均动脉压是丙泊酚联合阿片致血流动力学不稳的显著非遗传预测因素。
- GABRB1 rs4694846、OPRM1 rs1799971、CES2 rs8192925与较高心率不稳相关。
- NR1I2 rs6438550、BDNF rs2049046、GABBR2 rs1167768与较高平均动脉压不稳相关。
核心结论
- 心血管基础指标及GABRB1、GABBR2、OPRM1、BDNF、CES2和NR1I2遗传变异与丙泊酚和阿片类诱导的心血管易感性相关,可为临床麻醉血流动力学管理提供参考。
研究设计与样本
- 回顾性临床研究,纳入150例接受甲状腺或乳腺手术的中国患者,记录丙泊酚靶控输注浓度、阿片剂量、心率、平均动脉压及Narcotrend指数,并使用Agena MassARRAY系统对丙泊酚和阿片类药物药效学与药代动力学相关候选单核苷酸多态性进行基因分型。
主要发现
- 非遗传因素中,基线心率(R=-.579,P<.001)和基线平均动脉压(R=-.725,P<.001)对血流动力学不稳有显著影响。
- GABRB1 rs4694846的CT/CC基因型(95%CI:-11.309至-3.155)、OPRM1 rs1799971的AA/AG(95%CI:0.773至10.290)、CES2 rs8192925的AA(95%CI:1.842至9.090)与较高的心率不稳相关。
- NR1I2 rs6438550的AA/GG基因型(95%CI:0.351至7.761)、BDNF rs2049046的AA(95%CI:-9.039至-0.640)及GABBR2 rs1167768的GG(95%CI:-10.146至-1.740)与较高的平均动脉压不稳相关。
- 所建立的心率和平均动脉压波动预测模型分别可解释45.0%和59.2%的变异。
临床怎么用
- 临床麻醉中可关注患者基线心率与基线平均动脉压,以评估丙泊酚联合阿片类用药后血流动力学不稳的风险。
- GABRB1、OPRM1、CES2、NR1I2、BDNF及GABBR2相关基因变异信息可作为参考,辅助识别心率或平均动脉压易不稳的患者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIM: Propofol and opioids are commonly used in anaesthesia, but are highly susceptible to haemodynamic instability, thereby threatening the patient's surgical safety and prognosis. The purpose of this study was to investigate the predictors of haemodynamic instability and establish its predictive model. METHODS: A total of 150 Chinese patients undergoing thyroid or breast surgery participated in the study, with target-controlled infusion concentrations of propofol, opioids dosage, heart rate (HR), mean arterial pressure (MAP) and Narcotrend Index recorded at key points throughout the procedure. The Agena MassARRAY system was used to genotype candidate single nucleotide polymorphisms related to pharmacodynamics and pharmacokinetics of propofol and opioids. RESULTS: Among nongenetic factors, baseline HR (R = -.579, P < .001) and baseline MAP (R = -.725, P < .001) had a significant effect on the haemodynamic instability. Among genetic factors, the CT/CC genotype of GABRB1 rs4694846 (95% confidence interval [CI]: -11.309 to -3.155), AA/AG of OPRM1 rs1799971 (95%CI: 0.773 to 10.290), AA of CES2 rs8192925 (95%CI: 1.842 to 9.090) were associated with higher HR instability; the AA/GG genotype of NR1I2 rs6438550 (95%CI: 0.351 to 7.761), AA of BDNF rs2049046 (95%CI: -9.039 to -0.640) and GG of GABBR2 rs1167768 (95%CI: -10.146 to -1.740) were associated with higher MAP instability. The predictive models of HR and MAP fluctuations were developed, accounting for 45.0 and 59.2% of variations, respectively. CONCLUSION: We found that cardiovascular fundamentals and genetic variants of GABRB1, GABBR2, OPRM1, BDNF, CES2 and NR1I2 are associated with cardiovascular susceptibility, which can provide a reference for haemodynamic management in clinical anaesthesia.
引用
- Gu QL, Xue FL, Zheng ZL, et al. Nongenetic and genetic predictors of haemodynamic instability induced by propofol and opioids: A retrospective clinical study. Br J Clin Pharmacol. 2022. PMID: 35939394. doi:10.1111/bcp.15480
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。